Azathioprine monotherapy for maintenance of remission in pediatric patients with autoimmune hepatitis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 43, Issue 3, 2006, Pages 353-356

  Banerjee, Sanjoy ^b   Rahhal, Riad ^b   Bishop, Warren P ^a  

^a UNIVERSITY OF IOWA   (United States)

^b NONE

Author keywords

Autoimmune hepatitis; Azathioprine; Monotherapy; Pediatrics

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; PREDNISOLONE;

ADOLESCENT; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DOSE RESPONSE; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; LEUKOPENIA; LIVER BIOPSY; MAINTENANCE THERAPY; MALE; MONOTHERAPY; PRIORITY JOURNAL; PSYCHOSIS; RELAPSE; REMISSION; SCHOOL CHILD; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADRENAL CORTEX HORMONES; ALANINE TRANSAMINASE; ANTIBODIES, ANTINUCLEAR; ASPARTATE AMINOTRANSFERASES; AUTOANTIBODIES; AZATHIOPRINE; CHILD; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER; MUSCLE, SMOOTH; PREDNISONE; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES;

EID: 33748568494     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpg.0000232331.93052.dd     Document Type: Article

References (14)

1. Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002;36:479-97.
2. Thiele DL. Autoimmune hepatitis. Clin Liver Dis 2005;9:635-46. [vi].
3. Wright EC, Seeff LB, Berk PD, et al. Treatment of chronic active hepatitis. An analysis of three controlled trials. Gastroenterology 1977;73:1422-30.
4. Johnson PJ, McFarlane IG, Williams R. Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med 1995;333:958-63.
5. Ebbeson RL, Schreiber RA. Diagnosing autoimmune hepatitis in children: is the International Autoimmune Hepatitis Group scoring system useful? Clin Gastroenterol Hepatol 2004;2:935-40.
6. Gregorio GV, Portmann B, Reid F, et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 1997;25:541-7.
7. Summerskill WH, Korman MG, Ammon HV, et al. Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared. Gut 1975;16:876-83.
8. Mieli-Vergani G, Vergani D. Autoimmune hepatitis in children. Clin Liver Dis 2002;6:623-34.
9. Rumbo C, Emerick KM, Emre S, et al. Azathioprine metabolite measurements in the treatment of autoimmune hepatitis in pediatric patients: a preliminary report. J Pediatr Gastroenterol Nutr 2002;35:391-8.
10. Vergani D, Choudhuri K, Bogdanos DP, et al. Pathogenesis of autoimmune hepatitis. Clin Liver Dis 2002;6:727-37.
11. Prince HE, Ettenger RB, Dorey FJ, et al. Azathioprine suppression of natural killer activity and antibody-dependent cellular cytotoxicity in renal transplant recipients. J Clin Immunol 1984;4:312-8.
12. Pedersen BK, Beyer JM. A longitudinal study of the influence of azathioprine on natural killer cell activity. Allergy 1986;41:286-9.
13. Stellon AJ, Hegarty JE, Portmann B, et al. Randomised controlled trial of azathioprine withdrawal in autoimmune chronic active hepatitis. Lancet 1985;1:668-70.
14. Rumbo C, Shneider BL, Emre SH. Utility of azathioprine metabolite measurements in post-transplant recurrent autoimmune and immune-mediated hepatitis. Pediatr Transplant 2004;8:571-5.